Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, April 10, 2025

Colchicine prevents rise in total plaque volume for patients with stable CAD

 I bet we don't have enough brains in stroke to say; 'Maybe this would help in stroke also!'
  • colchicine (23 posts to December 2011)
  • I bet your incompetent doctor and hospital DID NOTHING WITH THIS EARLIER RESEARCH! That's why they are incompetent! DOING NOTHING!

    Colchicine prevents rise in total plaque volume for patients with stable CAD

    Key takeaways:

    • For patients with stable coronary artery disease, colchicine conferred lower total plaque volume as measured by coronary CT angiography vs. placebo.
    • There was no effect on volume of low attenuation plaque.

    CHICAGO — Among patients with stable coronary artery disease, colchicine lowered total plaque volume compared with placebo but had no impact on low attenuation plaque volume, researchers reported.

    “If we can show both outcome data and mechanistic plaque data that are concordant, we should ... get more comfortable with these interventions, and I think colchicine is going to be one that will be used more in clinical practice based on the available clinical data,” Matthew J. Budoff, MD, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, professor of medicine at the David Geffen School of Medicine at UCLA and program director and director of cardiac CT, division of cardiology, at Harbor-UCLA Medical Center, told Healio.














    Data were derived from Budoff MJ, et al. Featured clinical research IV. Presented at: American College of Cardiology Scientific Session; March 29-31, 2025; Chicago (hybrid meeting).     

    No comments:

    Post a Comment